FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss

First reported by CNBC at Tue 8:43 AM · 6 outlets in all

1. CNN18hFDA warns weight loss drugs may increase risk of sudden vision loss
2. Guardian20hFDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
3. MarketWatch22hThe FDA now says Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision lossSeveral medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.
4. AP23hFDA adds rare vision-loss warning to popular GLP-1 drugs
5. Ars Technica25hFDA warns GLP-1 drugs may pose risk of rare condition that causes vision lossThe risk appears small and data is mixed, but FDA wants patients to be aware.
6. CNBC25hFDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, ZepboundThe agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.